IQVIA’s Market Access Insights provides you with comprehensive, relevant, and actionable content so that you can make informed market access decisions.
Gain access to simple, powerful searches with up-to-date, easy-to-navigate results and the option of data analysis and visualizations – all in one place. Leverage Market Access Insights to get latest information on HTA reviews, reimbursement decisions, regulatory updates, clinical trials, and pricing. Access to data is flexible and customizable, so you can choose between export the data yourself or work with our experienced team for reports, assessments, trackers and more.
Find HTA, reimbursement and regulatory outcomes by product, disease and country in seconds
Explore the key factors driving decision making using advanced search capabilities
Drill down from high-level results to detailed information with a few clicks
Receive daily newsfeeds and email alerts
Identify trends and insights across many HTA and reimbursement decisions at a glance with our dashboards
Find information in one place to save time and effort on research and analysis
Accelerate research and analysis in a highly responsive cloud-based platform
Improve decision-making based on accurate and consistent information
See the range of information that’s available in Market Access Insights
Gain insights into HTA reviews and reimbursement decisions by accessing >50,000 HTA publications from >40 countries.
Access clinical data with >6,000 clinical records from clinicaltrials.gov.
Leverage regulatory information from around the world via >8,000 regulatory records from the US, EU, UK, Australia, Canada, and Japan.
Utilize pricing information on >6,000 products, information from >900 agreements, and treatment cost data.
Daily tracking for policy updates on >100 agencies to ensure you’re up to date on policy changes.
Obtaining and keeping market access for your drug is not a one-time activity, but decisions need to be made throughout the entire product lifecycle, from early-stage development through lifecycle management. Click on the stages to learn how Market Access Insights can provide value throughout a product’s lifecycle.
Understand how payers, providers, and patients define value, and accelerate market access for new and innovative products.
Access clearer, more compelling support to demonstrate the value of your product.
IQVIA Clinical Outcome Assessments (COAs) is dedicated to the licensing, distribution, translation, and scientific support for the use of our fit-for-purpose questionnaires to confidently measure various healthcare-related outcomes.
.svg){kind=icon}
